July 2nd, 2026
Intermittent mild hypoxia has been shown to slow aging and improve health in animal studies, and is used in medicine in some contexts. It is a form of stress and encourages a hormetic response from cells that on balance improves health. Long term hypoxia or severe hypoxia tips over into outright harm, overwhelming any beneficial mechanisms that attempt to compensate. Human data suggests that high altitude living, at the point where mild hypoxia is induced by the lower oxygen content of the air, results in accelerated aging. For example, researchers have shown that these populations exhibit accelerated immune aging. These populations are not yet large enough or well studied enough to go much beyond this sort of investigation of a few aspects of their physiology. Epidemiology for more solid evidence of accelerated aging is lacking, for example, and much of the existing data on mortality and age-related disease could be explained by comparative poverty rather than any sort of comprehensive acceleration of aging.
Recall that epigenetic age is usually assessed from a blood sample, and the only cells in a blood sample with nuclei and nuclear DNA are immune cells. Thus epigenetic age assays are really a measure of immune aging rather than systemic aging. To the degree that those two correlate, this is fine. But they are not the same thing, and the immune system is subject to pressures and mechanisms not relevant to other cell types in other tissues. Thus epigenetic age in those other cell types and tissues is more interesting in a research context.
